News Summary: Amgen 3Q profit up as sales rise

Associated Press
FILE - This April 20, 2010, file photo,shows an exterior view of Amgen offices in Fremont, Calif.  Biotech drugmaker Amgen Inc. said Tuesday , Oct. 23, 2012, that its third-quarter profit more than doubled from a year ago, when a huge legal reserve charge weighed down results. (AP Photo/Paul Sakuma, file)
.

View photo

FILE - This April 20, 2010, file photo,shows an exterior view of Amgen offices in Fremont, Calif. Biotech drugmaker Amgen Inc. said Tuesday , Oct. 23, 2012, that its third-quarter profit more than doubled from a year ago, when a huge legal reserve charge weighed down results. (AP Photo/Paul Sakuma, file)

THE OUTCOME: Third-quarter profit more than doubles for biotech drugmaker Amgen Inc., mainly because of a $780 million legal charge a year earlier to settle investigations into kickbacks and marketing practices.

THE NUMBERS: Net income was $1.11 billion, or $1.41 per share, up from $454 million, or 50 cents a share. Adjusted income was $1.31 billion, or $1.67 per share, beating analyst' expectation of $1.48. Sales rose 10 percent, to $4.32 billion.

THE FUTURE: The Thousand Oaks, Calif., company raised its 2012 forecast to adjusted profit of $6.50 to $6.60 per share, and sales of $17.2 billion to $17.3 billion.

Sorry you didn't like this comment. Please provide a reason below.

Are you sure?
Rating failed. Try again.
Request failed. Try again.
We will promote constructive and witty comments to the top, so everyone sees them!
Sorry, we can’t load comments right now. Try again.

    Recommended for You